How I manage frontline transplant-eligible multiple myeloma in Italy
The treatment of transplant-eligible multiple myeloma patients in Italy consists in an induction phase based on bortezomib plus thalidomide plus dexamethasone (VTd), followed by a single or tandem autologous stem cell transplantation (ASCT), followed by lenalidomide maintenance. This approach offers...
| الحاوية / القاعدة: | Hematology Reports |
|---|---|
| المؤلفون الرئيسيون: | , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
MDPI AG
2020-09-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.pagepress.org/journals/index.php/hr/article/view/8954 |